Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kate Hanrott
Observed names:
K.E. Hanrott,
Kate E. Hanrott
Institutions:
Iceland GeoSurvey,
Environment Agency of Iceland,
Icelandic Transport Authority,
Icelandic Cancer Society
Observed institutions:
GlaxoSmithKline (United Kingdom),
Iceland GeoSurvey,
Environment Agency of Iceland,
Icelandic Transport Authority,
Icelandic Cancer Society,
GlaxoSmithKline Research & Development Limited (United Kingdom)
show all 6
ORCID:
0000-0002-9629-8491
Observed ORCID:
0000-0002-9629-8491
OpenAlex ID:
A5049473118
Investigation of selective JAK1 inhibitor GSK2586184 for the treatment of psoriasis in a randomized placebo-controlled phase IIa study
2016
·
V.J. Ludbrook
, K.J. Hicks
, et al.
·
British Journal of Dermatology
·
86
A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR)
2022
·
Jatin Patel
, Damon Bass
, et al.
·
European Respiratory Journal
·
60
PDF
Adaptive study design to assess effect of TRPV4 inhibition in patients with chronic cough
2021
·
Valerie J. Ludbrook
, Kate E. Hanrott
, et al.
·
ERJ Open Research
·
39
PDF
An open‐label, dose‐escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of GSK2586881 in participants with pulmonary arterial hypertension
2021
·
Marc A. Simon
, Kate Hanrott
, et al.
·
Pulmonary Circulation
·
17
PDF
Effects of Recombinant Human Angiotensin-Converting Enzyme 2 on Response to Acute Hypoxia and Exercise: A Randomised, Placebo-Controlled Study
2021
·
David A. Hall
, Kate Hanrott
, et al.
·
Pulmonary Therapy
·
9
PDF
A randomised controlled trial of EP395, a novel anti-inflammatory macrolide, in stable COPD patients
2025
·
Henrik Watz
, Stephanie Korn
, et al.
·
ERJ Open Research
·
7
Effect of EP395, a novel anti-inflammatory macrolide, in an inhaled lipopolysaccharide challenge model in healthy volunteers: a randomised controlled trial
2025
·
Jens M. Hohlfeld
, Philipp Badorrek
, et al.
·
Pulmonary Pharmacology & Therapeutics
·
6
Early clinical pharmacology evaluation of the novel anti‐inflammatory macrolide, glasmacinal (EP395): tolerability, pharmacokinetics and drug interactions
2026
·
Dave Singh
, Kate Hanrott
, et al.
·
British Journal of Clinical Pharmacology
·
1
Late Breaking Abstract - A novel macrolide, EP395, in patients with stable COPD: a RCT
2024
·
Henrik Watz
, Stephanie Korn
, et al.
·
European Respiratory Journal
·
1
Study to Explore the Association of the Renin-Angiotensin System and Right Ventricular Function in Mechanically Ventilated Patients
2022
·
Armand Mekontso Dessap
, Kate Hanrott
, et al.
·
Journal of Clinical Medicine
·
1
PDF
Impact of the anti-inflammatory macrolide glasmacinal on the gut microbiota of healthy adults: an open-label trial
2026
·
Tsegaye Sewunet
, Mohammad Razavi
, et al.
·
Nature Communications
PDF
Late Breaking Abstract - A novel macrolide, EP395, in a LPS challenge in healthy volunteers
2024
·
Jens Hohlfeld
, Philipp Badorrek
, et al.
·
European Respiratory Journal
Show more works
View as search
Works count:
12
Citation count:
227
H-index:
6
I10-index:
4
Year
Topic
Type